McNamee M J, Coveney C M, Faulkner A, Gabe J
College of Engineering, Swansea University, Swansea, UK.
De Montfort University, Leicester, UK.
Health Care Anal. 2018 Dec;26(4):344-361. doi: 10.1007/s10728-017-0345-7.
The use of platelet rich plasma (PRP) as a novel treatment is discussed in the context of a qualitative research study comprising 38 interviews with sports medicine practitioners and other stakeholders working within the English Premier League during the 2013-16 seasons. Analysis of the data produced several overarching themes: conservatism versus experimentalism in medical attitudes; therapy perspectives divergence; conflicting versions of appropriate evidence; subcultures; community beliefs/practices; and negotiation of medical decision-making. The contested evidence base for the efficacy of PRP is presented in the context of a broader professional shift towards evidence based medicine within sports medicine. Many of the participants while accepting this shift are still committed to casuistic practices where clinical judgment is flexible and does not recognize a context-free hierarchy of evidentiary standards to ethically justifiable practice. We also discuss a tendency in the data collected to consider the use of deceptive, placebo-like, practices among the clinician participants that challenge dominant understandings of informed consent in medical ethics. We conclude that the complex relation between evidence and ethics requires greater critical scrutiny for this emerging specialism within the medical community.
在一项定性研究的背景下,探讨了使用富含血小板血浆(PRP)作为一种新型治疗方法的情况。该研究包括在2013 - 16赛季对英超联赛中的运动医学从业者和其他利益相关者进行的38次访谈。数据分析产生了几个总体主题:医学态度中的保守主义与实验主义;治疗观点的分歧;适当证据的相互冲突版本;亚文化;社区信仰/实践;以及医学决策的协商。在运动医学中向循证医学的更广泛专业转变的背景下,介绍了PRP疗效的有争议的证据基础。许多参与者虽然接受这种转变,但仍致力于判例法实践,即临床判断灵活,不认可在符合伦理的合理实践中存在脱离背景的证据标准等级制度。我们还讨论了在收集的数据中存在的一种趋势,即在临床医生参与者中考虑使用欺骗性、类似安慰剂的做法,这对医学伦理中知情同意的主流理解提出了挑战。我们得出结论,证据与伦理之间的复杂关系需要医学界对这一新兴专业进行更严格的审视。